FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Aman Buzdar

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Postmenopause

Co-author Network

Publications

TOP 3
Catherine M Kelly; Aman U Buzdar
Using multiple targeted therapies in oncology: considerations for use, and progress to date in breast cancer.
Celine M Vachon; Richard M Weinshilboum; Fang-Fang Wu; Kathleen R Brandt; Aman U Buzdar; Catherine R Elliott; Lynn M Flickinger; Paul E Goss; Matthew L Kosel; Janet E Olson; Lois Shepherd; Vera J Suman; Giske Ursin; James N Ingle
Mammographic breast density response to aromatase inhibition.
Mohan Liu; Yusuke Nakamura; Donald W Northfelt; Edith A Perez; Tracy L Pietrzak; Mark Robson; Daniel J Schaid; Liewei Wang; Anthony Batzler; Aman U Buzdar; Erin E Carlson; Brooke L Fridley; Matthew P Goetz; James N Ingle; Gregory D Jenkins; Michiaki Kubo; Clark V Williard; Richard M Weinshilboum
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Aman Buzdar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Catherine M Kelly; Aman U Buzdar
Using multiple targeted therapies in oncology: considerations for use, and progress to date in breast cancer.
Drugs 2013;73(6):505-15.
2013: Celine M Vachon; Richard M Weinshilboum; Fang-Fang Wu; Kathleen R Brandt; Aman U Buzdar; Catherine R Elliott; Lynn M Flickinger; Paul E Goss; Matthew L Kosel; Janet E Olson; Lois Shepherd; Vera J Suman; Giske Ursin; James N Ingle
Mammographic breast density response to aromatase inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(8):2144-53.
2013: Mohan Liu; Yusuke Nakamura; Donald W Northfelt; Edith A Perez; Tracy L Pietrzak; Mark Robson; Daniel J Schaid; Liewei Wang; Anthony Batzler; Aman U Buzdar; Erin E Carlson; Brooke L Fridley; Matthew P Goetz; James N Ingle; Gregory D Jenkins; Michiaki Kubo; Clark V Williard; Richard M Weinshilboum
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
Molecular endocrinology (Baltimore, Md.) 2013;27(4):657-70.
2013: Paul E Goss; William Gradishar; Manfred Kaufmann; Deborah Lindquist; Miguel Martin; Beverly Moy; Joyce O'Shaughnessy; Martine Piccart-Gebhart; Kathleen I Pritchard; Erica Rappold; Ian E Smith; Lisa S Williams; Gursel Aktan; Frances Boyle; Aman U Buzdar; Yanin Chavarri-Guerra; Bent Ejlertsen; Dianne M Finkelstein; Pierre Fumoleau
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
The lancet oncology 2013;14(1):88-96.
2012: Gary H Lyman; Harold J Burstein; Aman U Buzdar; Ralph D'Agostino; Paul A Ellis
Making genuine progress against metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(28):3448-51.
2012: Eun-Jung Jung; Juyeon Kim; Xiao-Feng Le; Erica Moretti; Soon-Tae Park; Lajos Pusztai; Libero Santarpia; Robert C Bast; Aman U Buzdar; Angelo Di Leo; Francisco J Esteva; George A Calin
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.
Cancer 2012;118(10):2603-14.
2012: Soley Bayraktar; Aman U Buzdar; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Henry M Kuerer; Xiudong Lei; Amal Melhem-Bertrandt; Aysegul A Sahin; Vicente Valero; Funda Meric-Bernstam
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.
Cancer 2012;118(9):2385-93.
2012: Catherine M Kelly; Aman U Buzdar
Aromatase inhibitors in premenopausal breast cancer.
The lancet oncology 2012;13(4):320-1.
2012: Catherine M Kelly; Eva S Thomas; Vicente Valero; Ronald S Walters; Daniel J Booser; Abenaa M Brewster; Kristine Broglio; Ana M Gonzalez-Angulo; Marjorie C Green; Gabriel N Hortobagyi; Kelly K Hunt; Nuhad K Ibrahim; Aman U Buzdar
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(9):930-5.
2012: Aman U Buzdar; S Cheporov; R Digumarti; L Goedhals; E Gotovkin; S Hoersch; X Hu; D W Miles; J O'Shaughnessy; K Rittweger; Vladimir Semiglazov; Sergei Tjulandin; B Xu
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):589-97.
2012: Michael S Ewer; Ming Yang; Aman U Buzdar
Screening for cardiac risk before anthracycline administration: what are the real benefits?
Clinical breast cancer 2012;12(1):1-3.
2012: Banu Arun; Abenaa Brewster; Aman U Buzdar; Francisco J Esteva; Marjorie Green; Angelica Gutierrez-Barrera; Gabriel N Hortobagyi; Diane Liu; Edgardo Rivera; Ugur Akar; Vicente Valero; Nour Sneige
Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
Cancer prevention research (Philadelphia, Pa.) 2012;5(2):276-82.
2011: Jack Cuzick; Mitch Dowsett; Ian O Ellis; Aman U Buzdar; Andrew R Green; Anthony Howell; Elizabeth Mallon; Silvia Pineda; Emma Quinn; Janine Salter; Christopher Wale; Lila Zabaglo; John F Forbes
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(32):4273-8.
2011: Alessandra Ferrajoli; Laura B Michaud; Aman U Buzdar; Lee Cheng; Yvette DeJesus; Maria A Rodriguez
Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia.
Cancer 2011;117(14):3268-75.
2011: Jeffrey M Albert; Pamela K Allen; Thomas A Buchholz; Aman U Buzdar; Reina Guzman; Karen E Hoffman; Kelly K Hunt; George H Perkins; Eric A Strom; Welela Tereffe; Wendy A Woodward; Julia L Oh
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control.
Breast cancer research and treatment 2011;128(2):421-7.
2011: Mitch Dowsett; John Forbes; Antony Howell; Elizabeth Mallon; S Pineda; Janine Salter; Lila Zabaglo; Aman U Buzdar; Jack Cuzick
Predictive algorithms for adjuvant therapy: TransATAC.
Steroids 2011;76(8):777-80.
2011: Elizabeth A Mittendorf; Jacqueline S Jeruss; Susan L Tucker; Aparna Kolli; Lisa A Newman; Ana M Gonzalez-Angulo; Thomas A Buchholz; Aysegul A Sahin; Janice N Cormier; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):1956-62.
2011: Aman U Buzdar
Anti-angiogenic therapies in metastatic breast cancer-an unfulfilled dream.
The lancet oncology 2011;12(4):316-8.
2011: Min Yi; Thomas A Buchholz; Funda Meric-Bernstam; Isabelle Bedrosian; Rosa F Hwang; Merrick I Ross; Henry M Kuerer; Sheng Luo; Ana M Gonzalez-Angulo; Aman U Buzdar; W Fraser Symmans; Barry W Feig; Anthony Lucci; Eugene H Huang; Kelly K Hunt
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
Annals of surgery 2011;253(3):572-9.
2011: Banu K Arun; Daniel Booser; Kristine Broglio; Aman U Buzdar; Kapil Dhinghra; Debbie Frye; Laura Guerra; Nuhad Ibrahim; Shu-Wan Kau; Merrick Ross; Aysegul Sahin; Nour Sneige; Eric Strom; Richard L Theriault; Saroj Vadhan-Raj; Vicente Valero; Ronald Walters; Guosheng Yin; Gabriel N Hortobagyi
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.
The oncologist 2011;16(11):1527-34.
2011: Henry M Kuerer; Aman U Buzdar; Elizabeth A Mittendorf; Francisco J Esteva; Anthony Lucci; Luis M Vence; Laszlo Radvanyi; Funda Meric-Bernstam; Kelly K Hunt; W Fraser Symmans
Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.
Cancer 2011;117(1):39-47.
2010: Catherine M Kelly; Aman U Buzdar
Anastrozole.
Expert opinion on drug safety 2010;9(6):995-1003.
2010: Chafika Mazouni; Keith Baggerly; David Hawke; Spyros Tsavachidis; Fabrice André; Aman U Buzdar; Pierre-Marie Martin; Ryuji Kobayashi; Lajos Pusztai
Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.
Proteomics 2010;10(19):3525-32.
2010: Jeffrey S Wefel; Angele K Saleeba; Aman U Buzdar; Christina A Meyers
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
Cancer 2010;116(14):3348-56.
2010: Laura S Dominici; Viviana M Negron Gonzalez; Aman U Buzdar; Anthony Lucci; Elizabeth A Mittendorf; Huong T Le-Petross; Gildy V Babiera; Funda Meric-Bernstam; Kelly K Hunt; Henry M Kuerer
Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
Cancer 2010;116(12):2884-9.
2010: James N Ingle; Aman U Buzdar; Daniel J Schaid; Matthew P Goetz; Anthony Batzler; Mark Robson; Donald W Northfelt; Janet E Olson; Edith A Perez; Zeruesenay Desta; Randy A Weintraub; Clark V Williard; David A Flockhart; Richard M Weinshilboum
Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer.
Cancer research 2010;70(8):3278-86.
2010: Stacy L Moulder; Frankie A Holmes; Anthony W Tolcher; Peter F Thall; Kristine Broglio; Vicente Valero; Aman U Buzdar; Susan G Arbuck; Andrew D Seidman; Gabriel N Hortobagyi
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.
Cancer 2010;116(4):814-21.
2010: Andre Robidoux; Aman U Buzdar; Emmanuel Quinaux; Samuel Jacobs; Priya Rastogi; Virginie Fourchotte; Rami J Younan; Eduardo R Pajon; Ibrahim A Shalaby; Ajit M Desai; Louis Fehrenbacher; Charles E Geyer; Eleftherios P Mamounas; Norman Wolmark
A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer.
Clinical breast cancer 2010;10(1):81-6.
2010: Catherine M Kelly; Aman U Buzdar
Aromatase inhibitors alone or in sequence with tamoxifen - clinical evaluation of the BIG 1-98 trial.
Expert opinion on pharmacotherapy 2010;11(3):489-92.
2010: Shaheenah Dawood; Kristine Broglio; Aman U Buzdar; Gabriel N Hortobagyi; Sharon H Giordano
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):92-8.
2009: Kellie L Jones; Aman U Buzdar
Evolving novel anti-HER2 strategies.
The lancet oncology 2009;10(12):1179-87.
2009: Elizabeth A Mittendorf; Yun Wu; Maurizio Scaltriti; Funda Meric-Bernstam; Kelly K Hunt; Shaheenah Dawood; Francisco J Esteva; Aman U Buzdar; Huiqin Chen; Sameena Eksambi; Gabriel N Hortobagyi; Jose Baselga; Ana M Gonzalez-Angulo
Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7381-8.
2009: Aman U Buzdar
Medical oncology: Endocrine-therapy-related symptoms and breast cancer.
Nature reviews. Clinical oncology 2009;6(6):309-10.
2009: Aman U Buzdar
Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(6):993-9.
2008: Florentia Peintinger; Aman U Buzdar; Henry M Kuerer; Jaime A Mejia, M.D.; Christos Hatzis; Ana M Gonzalez-Angulo; Lajos Pusztai; Francisco J Esteva; S S Dawood; Marjorie C Green; Gabriel N Hortobagyi; W Fraser Symmans
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(12):2020-5.
2008: Shaheenah Dawood; Kristine Broglio; Ana M Gonzalez-Angulo; Aman U Buzdar; Gabriel N Hortobagyi; Sharon H Giordano
Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4891-8.
2008: Aman U Buzdar
Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer.
Drugs of today (Barcelona, Spain : 1998) 2008;44(9):679-92.
2008: Jennifer K Litton; Ana M Gonzalez-Angulo; Carla L Warneke; Aman U Buzdar; Shu-Wan Kau; Melissa L Bondy; Somdat Mahabir; Gabriel N Hortobagyi; Abenaa M Brewster
Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4072-7.
2008: Ivana Sestak; Jack Cuzick; Francisco Sapunar; Ana Munoz; John F Forbes; Angelo R Bianco; Aman U Buzdar
Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.
The lancet oncology 2008;9(9):866-72.
2008: Abenaa M Brewster; Gabriel N Hortobagyi; Kristine R Broglio; Shu-Wan Kau; Cesar A Santa-Maria; Banu Arun; Aman U Buzdar; Daniel J Booser; Vincente Valero; Melissa Bondy; Francisco J Esteva
Residual risk of breast cancer recurrence 5 years after adjuvant therapy.
Journal of the National Cancer Institute 2008;100(16):1179-83.
2008: Jacqueline S Jeruss; Elizabeth A Mittendorf; Susan L Tucker; Ana M Gonzalez-Angulo; Thomas A Buchholz; Aysegul A Sahin; Janice N Cormier; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Staging of breast cancer in the neoadjuvant setting.
Cancer research 2008;68(16):6477-81.
2008: Aman U Buzdar
Clinical experience with epothilones in patients with breast cancer.
Clinical breast cancer 2008;8 Suppl 2():S71-8.
2008: Julie R Gralow; Harold J Burstein; William Wood; Gabriel N Hortobagyi; Luca Gianni; Gunter von Minckwitz; Aman U Buzdar; Ian E Smith; William F Symmans; Baljit Singh; Eric P Winer
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):814-9.
2008: Aman U Buzdar; R Charles Coombes; Paul E Goss; Eric P Winer
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.
Cancer 2008;112(3 Suppl):700-9.
2008: Steven E Come; Aman U Buzdar; James N Ingle; Stephen R D Johnston; Angela Brodie; R Charles Coombes; William R Miller; Kathleen I Pritchard; Eric P Winer; Jo Anne Zujewski; Paul E Goss
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Cancer 2008;112(3 Suppl):673-8.
2008: Jacqueline S Jeruss; Elizabeth A Mittendorf; Susan L Tucker; Ana M Gonzalez-Angulo; Thomas Buchholz; Aysegul A Sahin; Janice N Cormier; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):246-52.
2008: Lee R Jackson; Kwok L Cheung; Aman U Buzdar; John F R Robertson
Arzoxifene: the evidence for its development in the management of breast cancer.
Core evidence 2008;2(4):251-8.
2008: Judy C Boughey; Aman U Buzdar; Kelly K Hunt
Recent advances in the hormonal treatment of breast cancer.
Current problems in surgery 2008;45(1):13-55.
2008: Judy C Boughey; Aman U Buzdar; Kelly K Hunt
In brief.
Current problems in surgery 2008;45(1):6-11.
2007: Aman U Buzdar
Preoperative chemotherapy treatment of breast cancer--a review.
Cancer 2007;110(11):2394-407.
2007: Vijayalaxmi Deshmane; S Krishnamurthy; Allen S Melemed; Patrick Peterson; Aman U Buzdar
Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4967-73.
2007: W Fraser Symmans; Florentia Peintinger; Christos Hatzis; Radhika Rajan; Henry M Kuerer; Vicente Valero; Lina Assad; Anna Poniecka; Bryan T. J. Hennessy; Marjorie Green; Aman U Buzdar; S Eva Singletary; Gabriel N Hortobagyi; Lajos Pusztai
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4414-22.
2007: Massimo Cristofanilli; Vicente Valero; Aman U Buzdar; Shu-Wan Kau; Kristine Broglio; Ana M Gonzalez-Angulo; Nour Sneige; Rabiul Islam; Naoto T Ueno; Thomas Buchholz; S Eva Singletary; Gabriel N Hortobagyi
Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
Cancer 2007;110(7):1436-44.
2007: Shaheenah Dawood; Ana M Gonzalez-Angulo; Florentia Peintinger; Kristine Broglio; W Fraser Symmans; Shu-Wan Kau; Rabiul Islam; Gabriel N Hortobagyi; Aman U Buzdar
Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.
Cancer 2007;110(6):1195-200.
2007: Ana M Gonzalez-Angulo; Bryan T. J. Hennessy; Kristine Broglio; Funda Meric-Bernstam; Massimo Cristofanilli; Sharon H Giordano; Thomas Buchholz; Aysegul Sahin; S Eva Singletary; Aman U Buzdar; Gabriel N Hortobágyi
Trends for inflammatory breast cancer: is survival improving?
The oncologist 2007;12(8):904-12.
2007: Aman U Buzdar
Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2147-8; author reply 2148.
2007: Aman U Buzdar
Adjuvant chemotherapy for high-risk operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1642-4.
2007: Chafika Mazouni; Shu-Wan Kau; Debra Frye; Fabrice Andre; Henry M Kuerer; Thomas Buchholz; W Fraser Symmans; Keith Anderson; Kenneth R Hess; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Aman U Buzdar; Lajos Pusztai
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):874-80.
2007: Chafika Mazouni; Angeline Hall; Kristine Broglio; Herbert A Fritsche; Fabrice Andre; Francisco J Esteva; Gabriel N Hortobagyi; Aman U Buzdar; Lajos Pusztai; Massimo Cristofanilli
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.
Cancer 2007;109(3):496-501.
2007: Francisco J Esteva; Jing Wang; Feng Lin; Jaime A Mejia, M.D.; Kai Yan; Kadri Altundag; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
Breast cancer research : BCR 2007;9(6):R87.
2007: Ricardo J Gonzalez; Aman U Buzdar; W Fraser Symmans; Tina W F Yen; Kristine Broglio; Anthony Lucci; Francisco J Esteva; Guosheng Yin; Henry M Kuerer
Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin).
The breast journal 2007;13(1):72-5.
2007: Aman U Buzdar; Vicente Valero; Nuhad K Ibrahim; Deborah Francis; Kristine Broglio; Richard L Theriault; Lajos Pusztai; Marjorie C Green; S Eva Singletary; Kelly K Hunt; Aysegul A Sahin; Francisco J Esteva; W Fraser Symmans; Michael S Ewer; Thomas Buchholz; Gabriel N Hortobagyi
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):228-33.
2006: Florentia Peintinger; Henry M Kuerer; Keith Anderson; Judy C Boughey; Funda Meric-Bernstam; S Eva Singletary; Kelly K Hunt; Gary J Whitman; Tanya W Stephens; Aman U Buzdar; Marjorie C Green; W Fraser Symmans
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Annals of surgical oncology 2006;13(11):1443-9.
2006: Florentia Peintinger; W Fraser Symmans; Ana M Gonzalez-Angulo; Judy C Boughey; Aman U Buzdar; Tse-Kuan Yu; Kelly K Hunt; S Eva Singletary; Gildy V Babiera; Anthony Lucci; Funda Meric-Bernstam; Henry M Kuerer
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
Cancer 2006;107(6):1248-54.
2006: Kenneth R Hess; Keith Anderson; W Fraser Symmans; Vicente Valero; Nuhad Ibrahim; Jaime A Mejia, M.D.; Daniel J Booser; Richard L Theriault; Aman U Buzdar; Peter J Dempsey; Roman Rouzier; Nour Sneige; Jeffrey S Ross; Tatiana Vidaurre; Henry L Gómez; Gabriel N Hortobagyi; Lajos Pusztai
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4236-44.
2006: Judy C Boughey; Florentia Peintinger; Funda Meric-Bernstam; Allison C Perry; Kelly K Hunt; Gildy V Babiera; S E Singletary; Isabelle Bedrosian; Anthony Lucci; Aman U Buzdar; Lajos Pusztai; Henry M Kuerer
Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.
Annals of surgery 2006;244(3):464-70.
2006: Aman U Buzdar; John F R Robertson
Fulvestrant: pharmacologic profile versus existing endocrine agents for the treatment of breast cancer.
The Annals of pharmacotherapy 2006;40(9):1572-83.
2006: Aman U Buzdar; Rowan T Chlebowski; Jack Cuzick; Stephen W Duffy; John Forbes; Walter Jonat; Peter M Ravdin
Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
Current medical research and opinion 2006;22(8):1575-85.
2006: Aman U Buzdar; Jean-Paul Guastalla; Jean-Marc Nabholtz; Jack Cuzick
Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial.
Cancer 2006;107(3):472-80.
2006: Thomas Buchholz; Eric A Strom; Mary Jane Oswald; George H Perkins; Julia Oh; Delora Domain; Tse-Kuan Yu; Wendy A Woodward; Welela Tereffe; S Eva Singletary; Eva Thomas; Aman U Buzdar; Gabriel N Hortobagyi; Marsha D McNeese
Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
International journal of radiation oncology, biology, physics 2006;65(4):1155-60.
2006: Aman U Buzdar
Anastrozole for breast cancer: recent advances and ongoing challenges.
Expert review of anticancer therapy 2006;6(6):839-48.
2006: Aman U Buzdar
Topoisomerase IIalpha gene amplification and response to anthracycline-containing adjuvant chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2409-11.
2006: Emer O Hanrahan; Kristine Broglio; Debra Frye; Aman U Buzdar; Richard L Theriault; Vicente Valero; Daniel J Booser; S Eva Singletary; Eric A Strom; James L Gajewski; Richard E Champlin; Gabriel N Hortobagyi
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Cancer 2006;106(11):2327-36.
2006: Luigi Cataliotti; Aman U Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsuka; Katarina Petrakova; Pierre Dube; Celia Tosello de Oliveira
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
Cancer 2006;106(10):2095-103.
2006: Aman U Buzdar
Update on the management of inflammatory breast cancer.
Clinical advances in hematology & oncology : H&O 2006;4(5):344-5.
2006: Aman U Buzdar; Michael Baum; Jack Cuzick
Letrozole or tamoxifen in early breast cancer.
The New England journal of medicine 2006;354(14):1528-30; author reply 1528-30.
2006: Valentina Guarneri; Kristine Broglio; Shu-Wan Kau; Massimo Cristofanilli; Aman U Buzdar; Vicente Valero; Thomas Buchholz; Funda Meric; Lavinia P Middleton; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1037-44.
2006: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Massimo Cristofanilli; Shu-Wan Kau; Kristine Broglio; Bruno D Fornage; S Eva Singletary; Aysegul Sahin; Aman U Buzdar; Vicente Valero
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy.
Cancer 2006;106(5):1000-6.
2006: Aman U Buzdar
Dietary modification and risk of breast cancer.
JAMA : the journal of the American Medical Association 2006;295(6):691-2.
2006: Aman U Buzdar; Jack Cuzick
Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):1037s-1048s.
2006: Steven E Come; Aman U Buzdar; James N Ingle; Carlos L Arteaga; Myles Brown; Mitch Dowsett; Susan G Hilsenbeck; Rakesh Kumar; Stephen R D Johnston; Adrian V Lee; Soonmyung Paik; Kathleen I Pritchard; Eric P Winer; Carol Hart
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):997s-1000s.
2006: Anees B Chagpar; Lavinia P Middleton; Aysegul A Sahin; Peter J Dempsey; Aman U Buzdar; Attiqa N Mirza; Frederick C Ames; Gildy V Babiera; Barry W Feig; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Merrick I Ross; S Eva Singletary
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
Annals of surgery 2006;243(2):257-64.
2006: Hidetoshi Yamaya; Mayuko Saeki; Ken-ichiro Yoshida; Jiro Shibata; Shingo Yano; Yoshiaki Sato; Atsushi Takao; Takashi Shindo; Aman U Buzdar; Sekio Nagayama
Distribution of (7alpha)-21-[4-[(diethylamino) methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol-20-[14C]2-hydroxy-1,2,3-propanetricarboxylate ([14C]TAS-108) and its metabolites after single oral administration to rats bearing 7,12-dimethylbenz(alpha)anthracene-induced mammary tumor.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(2):331-8.
2005: Bryan T. J. Hennessy; Gabriel N Hortobagyi; Roman Rouzier; Henry M Kuerer; Nour Sneige; Aman U Buzdar; Shu-Wan Kau; Bruno D Fornage; Aysegul Sahin; Kristine Broglio; S Eva Singletary; Vicente Valero
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9304-11.
2005: Sharon H Giordano; George H Perkins; Kristine Broglio; Sherry G Garcia; Lavinia P Middleton; Aman U Buzdar; Gabriel N Hortobagyi
Adjuvant systemic therapy for male breast carcinoma.
Cancer 2005;104(11):2359-64.
2005: Aman U Buzdar; Jack Cuzick
Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8544-6; author reply 8546-7.
2005: Roman Rouzier; Lajos Pusztai; Suzette Delaloge; Ana M Gonzalez-Angulo; Fabrice Andre; Kenneth R Hess; Aman U Buzdar; Jean-Rémi Garbay; Marc Spielmann; Marie-Christine Mathieu; W Fraser Symmans; Peter Wagner; david atallah; Vicente Valero; Donald A Berry; Gabriel N Hortobagyi
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8331-9.
2005: Ana M Gonzalez-Angulo; Sean E McGuire; Thomas Buchholz; Susan L Tucker; Henry M Kuerer; Roman Rouzier; Shu-Wan Kau; Eugene H Huang; Paolo Morandi; Alberto Ocana; Massimo Cristofanilli; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7098-104.
2005: H Yamaya; K Yoshida; J Kuritani; J Yonezawa; J-I Yonezawa; M Tsuda; T Shindo; S Nagayama; Aman U Buzdar
Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose.
Journal of clinical pharmacy and therapeutics 2005;30(5):459-70.
2005: Emer O Hanrahan; Kristine Broglio; Aman U Buzdar; Richard L Theriault; Vicente Valero; Massimo Cristofanilli; Guosheng Yin; Shu-Wan Kau; Gabriel N Hortobagyi; Edgardo Rivera
Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
Cancer 2005;104(6):1158-71.
2005: Marjorie C Green; Aman U Buzdar; Terry Smith; Nuhad K Ibrahim; Vicente Valero; Marguerite F Rosales; Massimo Cristofanilli; Daniel J Booser; Lajos Pusztai; Edgardo Rivera; Richard L Theriault; Cynthia Carter; Debra Frye; Kelly K Hunt; W Fraser Symmans; Eric A Strom; Aysegul A Sahin; William Sikov; Gabriel N Hortobagyi
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5983-92.
2005: Alberto Montero; Roman Rouzier; Ana Lluch; Richard L Theriault; Aman U Buzdar; Suzette Delaloge; Begoñia Bermejo; Monique Le; Shu-Wan Kau; Ariane Dunant; Rodrigo Arriagada; Marc Spielmann; Javier Garcia-Conde; Aysegul A Sahin; S Eva Singletary; Gabriel N Hortobagyi; Vicente Valero
The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.
Cancer 2005;104(2):229-35.
2005: Ana M Gonzalez-Angulo; Kristine Broglio; Shu-Wan Kau; Yesim Eralp; Julie Erlichman; Vicente Valero; Richard Theriault; Daniel J Booser; Aman U Buzdar; Gabriel N Hortobagyi; Banu Arun
Women age < or = 35 years with primary breast carcinoma: disease features at presentation.
Cancer 2005;103(12):2466-72.
2005: Eugene H Huang; Susan L Tucker; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Gabriel N Hortobagyi; Aman U Buzdar; Vicente Valero; George H Perkins; Naomi R Schechter; Kelly K Hunt; Aysegul A Sahin; Thomas Buchholz
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
International journal of radiation oncology, biology, physics 2005;62(2):351-7.
2005: Aman U Buzdar; Nuhad K Ibrahim; Deborah Francis; Daniel J Booser; Eva S Thomas; Richard L Theriault; Lajos Pusztai; Marjorie C Green; Banu Arun; Sharon H Giordano; Massimo Cristofanilli; Debra Frye; Terry L Smith; Kelly K Hunt; S Eva Singletary; Aysegul A Sahin; Michael S Ewer; Thomas Buchholz; Donald Berry; Gabriel N Hortobagyi
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3676-85.
2005: Anthony Howell; Aman U Buzdar
Are aromatase inhibitors superior to antiestrogens?
The Journal of steroid biochemistry and molecular biology 2005;93(2-5):237-47.
2005: Aman U Buzdar
TAS-108: a novel steroidal antiestrogen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 2):906s-8s.
2005: Steven E Come; Aman U Buzdar; James N Ingle; Carlos L Arteaga; Angela Brodie; GRaham Colditz; Stephen R D Johnston; Vessela N Kristensen; Per Eystein Lønning; Donald P McDonnell; C Kent Osborne; Jose Russo; Richard J Santen; Douglas Yee; Carol S Hart
Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 2):861s-4s.
2005: Aman U Buzdar
Aromatase inhibitors: changing the face of endocrine therapy for breast cancer.
Breast disease 2005;24():107-17.
2005: Yasuji Yamamoto; Jiro Shibata; Kazuhiko Yonekura; Kouji Sato; Akihiro Hashimoto; Yoshimi Aoyagi; Konstanty Wierzba; Shingo Yano; Tetsuji Asao; Aman U Buzdar; Tadafumi Terada
TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):315-22.
2005: Aman U Buzdar; Cynthia Macahilig
How rapidly do oncologists respond to clinical trial data?
The oncologist 2005;10(1):15-21.
2005: Massimo Cristofanilli; Ana M Gonzalez-Angulo; Nour Sneige; Shu-Wan Kau; Kristine Broglio; Richard L Theriault; Vicente Valero; Aman U Buzdar; Henry M Kuerer; Thomas A Buccholz; Gabriel N Hortobagyi
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):41-8.
2004: Eugene H Huang; Susan L Tucker; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Aman U Buzdar; Vicente Valero; George H Perkins; Naomi R Schechter; Kelly K Hunt; Aysegul A Sahin; Gabriel N Hortobagyi; Thomas Buchholz
Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4691-9.
2004: Tse-Kuan Yu; Gary J Whitman; Howard D Thames; Aman U Buzdar; Eric A Strom; George H Perkins; Naomi R Schechter; Marsha D McNeese; Shu-Wan Kau; Eva S Thomas; Gabriel N Hortobagyi; Thomas Buchholz
Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients.
Journal of the National Cancer Institute 2004;96(22):1676-81.
2004: Ana M Gonzalez-Angulo; Massimo Cristofanilli; Eric A Strom; Aman U Buzdar; Shu-Wan Kau; Kristine Broglio; Terry L Smith; Gabriel N Hortobagyi
Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
Cancer 2004;101(8):1760-6.
2004: Zhiyong Li; Nuhad K Ibrahim; J Kyle Wathen; Michael Wang; Rosario P Mante Menchu; Vicente Valero; Richard Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Colitis in patients with breast carcinoma treated with taxane-based chemotherapy.
Cancer 2004;101(7):1508-13.
2004: Paolo Morandi; Roman Rouzier; Kadri Altundag; Aman U Buzdar; Richard L Theriault; Gabriel Hortobagyi
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
Cancer 2004;101(7):1482-9.
2004: Ana M Gonzalez-Angulo; Nour Sneige; Aman U Buzdar; Vicente Valero; Shu-Wan Kau; Kristine Broglio; Yuko Yamamura; Gabriel N Hortobagyi; Massimo Cristofanilli
p53 expression as a prognostic marker in inflammatory breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6215-21.
2004: Aman U Buzdar
Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer.
Drugs of today (Barcelona, Spain : 1998) 2004;40(9):751-64.
2004: Kellie L Jones; Aman U Buzdar
A review of adjuvant hormonal therapy in breast cancer.
Endocrine-related cancer 2004;11(3):391-406.
2004: Aman U Buzdar
The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial: an update.
Clinical breast cancer 2004;5 Suppl 1():S6-S12.
2004: Aman U Buzdar
Current developments in hormonal therapy of breast cancer.
Clinical breast cancer 2004;5 Suppl 1():S4-5.
2004: Erika Resetkova; Ana M Gonzalez-Angulo; Nour Sneige; Timothy J McDonnell; Aman U Buzdar; Shu-Wan Kau; Yuko Yamamura; James M Reuben; Gabriel N Hortobagyi; Massimo Cristofanilli
Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma.
Cancer 2004;101(5):913-7.
2004: L Johnetta Blakely; Aman U Buzdar; Hsiu-Yin Chang; Debra Frye; Richard Theriault; Vicente Valero; Edgardo Rivera; Daniel J Booser; Jun Kuritani; Masuhiro Tsuda
A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5425-31.
2004: Aman U Buzdar
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3199-200; author reply 3200-1.
2004: Thomas Buchholz; Eugene H Huang; Donald Berry; Lajos Pusztai; Eric A Strom; Marsha D McNeese; George H Perkins; Naomi R Schechter; Henry M Kuerer; Aman U Buzdar; Vicente Valero; Kelly K Hunt; Gabriel N Hortobagyi; Aysegul A Sahin
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.
International journal of radiation oncology, biology, physics 2004;59(5):1337-42.
2004: Jeffrey S Wefel; Renato Lenzi; Richard Theriault; Aman U Buzdar; Scott Cruickshank; Christina A Meyers
'Chemobrain' in breast carcinoma?: a prologue.
Cancer 2004;101(3):466-75.
2004: Ana M Gonzalez-Angulo; Savitri Krishnamurthy; Yuko Yamamura; Kristine Broglio; Lajos Pusztai; Aman U Buzdar; Gabriel N Hortobagyi; Francisco J Esteva
Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma.
Cancer 2004;101(2):258-63.
2004: Sharon H Giordano; Deborah S Cohen; Aman U Buzdar; George Perkins; Gabriel N Hortobagyi
Breast carcinoma in men: a population-based study.
Cancer 2004;101(1):51-7.
2004: Eva Thomas; Frankie A Holmes; Terry L Smith; Aman U Buzdar; Debra Frye; Giuseppe Fraschini; S Eva Singletary; Richard L Theriault; Marsha D McNeese; Frederick C Ames; Ronald Walters; Gabriel N Hortobagyi
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2294-302.
2004: Aman U Buzdar; Ignace Vergote; Richard Sainsbury
The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
The breast journal 2004;10(3):211-7.
2004: Amit K Garg; Eric A Strom; Marsha D McNeese; Aman U Buzdar; Gabriel N Hortobagyi; Henry M Kuerer; George H Perkins; S Eva Singletary; Kelly K Hunt; Asyegul Sahin; Naomi R Schechter; Vicente Valero; Susan L Tucker; Thomas Buchholz
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
International journal of radiation oncology, biology, physics 2004;59(1):138-45.
2004: Jack Cuzick; Aman U Buzdar; Michael Baum; Raffaele Bianco; Robert Coleman; Manuel Constenla; Wolfgang Distler; Mitch Dowsett; John Forbes; Jean-Paul Guastalla; Joan Houghton; Norman Williams; Anthony Howell; Gershon Locker; John MacKey; Richard Sainsbury; Jeffrey Tobias
Adjuvant use of anastrozole in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1524-6; author reply 1526-7.
2004: Aman U Buzdar
Preoperative chemotherapy for breast cancer.
Clinical advances in hematology & oncology : H&O 2004;2(4):212, 215.
2004: Radhika Rajan; Anna Poniecka; Terry L Smith; Ying Yang; Deborah Frye; Lajos Pusztai; Derek J Fiterman; Eva Gal-Gombos; Gary J Whitman; Roman Rouzier; Marjorie Green; Henry M Kuerer; Aman U Buzdar; Gabriel N Hortobagyi; W Fraser Symmans
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
Cancer 2004;100(7):1365-73.
2004: Aman U Buzdar
Letrozole in breast cancer.
The New England journal of medicine 2004;350(7):727-30; author reply 727-30.
2004: Massimo Cristofanilli; Ana M Gonzalez-Angulo; Aman U Buzdar; Shu-Wan Kau; Debra Frye; Gabriel N Hortobagyi
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.
Clinical breast cancer 2004;4(6):415-9.
2004: Francisco J Esteva; Aysegul A Sahin; Terry L Smith; Ying Yang; Lajos Pusztai; Rita Nahta; Thomas Buchholz; Aman U Buzdar; Gabriel N Hortobagyi; Sarah S Bacus
Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
Cancer 2004;100(3):499-506.
2004: L Johnetta Blakely; Aman U Buzdar; Jose A Lozada; Samer A Shullaih; Emma Hoy; Terry L Smith; Gabriel N Hortobagyi
Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
Cancer 2004;100(3):465-9.
2004: Aman U Buzdar
Paclitaxel in early breast cancer: a viewpoint by Aman U. Buzdar.
Drugs 2004;64(16):1848-9.
2004: Aman U Buzdar
Hormonal therapy in early and advanced breast cancer.
The breast journal 2004;10 Suppl 1():S19-21.
2004: Aman U Buzdar
Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 2):355S-61S.
2004: Steven E Come; Aman U Buzdar; Carlos L Arteaga; Mina J Bissell; Myles Brown; Matthew J Ellis; Paul E Goss; Jeffrey E Green; James N Ingle; Adrian V Lee; Daniel Medina; Robert I Nicholson; Richard J Santen; Rachel Schiff; Carol S Hart
Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 2):327S-330S.
2004: Sharon H Giordano; Aman U Buzdar; Terry L Smith; Shu-Wan Kau; Ying Yang; Gabriel N Hortobagyi
Is breast cancer survival improving?
Cancer 2004;100(1):44-52.
2003: W Robert Simons; David Jones; Aman U Buzdar
Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer.
Clinical therapeutics 2003;25(11):2972-87.
2003: Aman U Buzdar
Aromatase inhibitors in breast cancer therapy.
Clinical breast cancer 2003;4 Suppl 2():S84-8.
2003: Michael Baum; Aman U Buzdar; Anthony Howell
ATAC trial did not report interim results.
BMJ (Clinical research ed.) 2003;327(7422):1050.
2003: Michael Baum; Aman U Buzdar; Jack Cuzick; John Forbes; J Houghton; A Howell; T Sahmoud
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
Cancer 2003;98(9):1802-10.
2003: Aman U Buzdar
Role of anastrozole in adjuvant therapy for postmenopausal patients.
Seminars in oncology 2003;30(5 Suppl 16):21-9.
2003: Aman U Buzdar
Breast cancer in men.
Oncology (Williston Park, N.Y.) 2003;17(10):1361-4; discussion 1364, 1369-72.
2003: Aman U Buzdar; Gabriel N Hortobagyi
Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer.
Cancer treatment reviews 2003;29(5):449-52.
2003: Wendy A Woodward; Eric A Strom; Susan L Tucker; Angela Katz; Marsha D McNeese; George H Perkins; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt; Aysegul Sahin; Funda Meric; Nour Sneige; Thomas Buchholz
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
International journal of radiation oncology, biology, physics 2003;57(2):336-44.
2003: Wendy A Woodward; Eric A Strom; Marsha D McNeese; George H Perkins; Eleysia L Outlaw; Gabriel N Hortobagyi; Aman U Buzdar; Thomas Buchholz
Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.
International journal of radiation oncology, biology, physics 2003;57(2):327-35.
2003: Aman U Buzdar
'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.
The Journal of steroid biochemistry and molecular biology 2003;86(3-5):399-403.
2003: Michael Baum; Aman U Buzdar
The current status of aromatase inhibitors in the management of breast cancer.
The Surgical clinics of North America 2003;83(4):973-94.
2003: John F R Robertson; C Kent Osborne; Anthony Howell; Stephen E Jones; Louis Mauriac; Matthew Ellis; Ulrich R Kleeberg; Steven E Come; Ignace Vergote; Stan Gertler; Aman U Buzdar; Alan Webster; Charles Morris
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.
Cancer 2003;98(2):229-38.
2003: W Fraser Symmans; Mark Ayers; Edwin A Clark; James Stec; Kenneth R Hess; Nour Sneige; Thomas Buchholz; Savitri Krishnamurthy; Nuhad K Ibrahim; Aman U Buzdar; Richard L Theriault; Marguerite F Rosales; Eva S Thomas; Karin Gwyn; Marjorie C Green; Abdul R Syed; Gabriel N Hortobagyi; Lajos Pusztai
Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.
Cancer 2003;97(12):2960-71.
2003: Vasily Assikis; Aman U Buzdar; Ying Yang; Terry Smith; Richard Theriault; Daniel J Booser; Vicente Valero; Ronald Walters; Eva Singletary; Frederick C Ames; Gabriel Hortobagyi
A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up.
Cancer 2003;97(11):2716-23.
2003: Filippo Montemurro; Gabriela Rondón; Mark F Munsell; Terry L Smith; Michele L Donato; James L Gajewski; Zia Rahman; Aman U Buzdar; Richard E Champlin; Naoto T Ueno
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(5):330-40.
2003: D Craig Allred; Michael Baum; Aman U Buzdar; Robert W Carlson; Mitchell Dowsett; Richard M Elledge; William J Gradishar; Generosa Grana; Anthony Howell; Eleftherios P Mamounas
A roundtable discussion of aromatase inhibitors as therapy for breast cancer.
The breast journal 2003;9(3):213-22.
2003: Aman U Buzdar
Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.
Clinical breast cancer 2003;4 Suppl 1():S42-8.
2003: Fan Zhang; Ying Yang; Terry Smith; Shu-Wan Kau; Judy M McConathy; Francisco J Esteva; Henry M Kuerer; W Fraser Symmans; Aman U Buzdar; Gabriel N Hortobagyi; Lajos Pusztai
Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.
Cancer 2003;97(7):1758-65.
2003: Aman U Buzdar; Joyce A O'Shaughnessy; Daniel J Booser; John Pippen; Stephen E Jones; Pamela N Munster; Patrick Peterson; Allen S Melemed; Eric P Winer; Clifford Hudis
Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1007-14.
2003: Kenneth R Hess; Lajos Pusztai; Aman U Buzdar; Gabriel N Hortobagyi
Estrogen receptors and distinct patterns of breast cancer relapse.
Breast cancer research and treatment 2003;78(1):105-18.
2003: Aman U Buzdar
Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
The oncologist 2003;8(4):335-41.
2003: Massimo Cristofanilli; Aman U Buzdar; Gabriel N Hortobágyi
Update on the management of inflammatory breast cancer.
The oncologist 2003;8(2):141-8.
2003: Aman U Buzdar
Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):468S-72S.
2003: Steven E Come; Aman U Buzdar; Carlos L Arteaga; Angela Brodie; Nancy E Davidson; Mitch Dowsett; James N Ingle; Stephen R D Johnston; Adrian V Lee; C Kent Osborne; Kathleen I Pritchard; Victor G Vogel; Eric P Winer; Carol S Hart
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):443S-6S.
2002: Aman U Buzdar
Anastrozole (Arimidex) in clinical practice versus the old 'gold standard', tamoxifen.
Expert review of anticancer therapy 2002;2(6):623-9.
2002: Sharon H Giordano; Daniel J Booser; James L Murray; Nuhad K Ibrahim; Zia Rahman; Vicente Valero; Richard L Theriault; Marguerite F Rosales; Edgardo Rivera; Debra Frye; Michael S Ewer; Nelson G Ordonez; Aman U Buzdar; Gabriel N Hortobagyi
A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3360-8.
2002: Aman U Buzdar; John F R Robertson; Wolfgang Eiermann; Jean-Marc Nabholtz
An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
Cancer 2002;95(9):2006-16.
2002: Sharon H Giordano; Aman U Buzdar; Gabriel N Hortobagyi
Breast cancer in men.
Annals of internal medicine 2002;137(8):678-87.
2002: Vicente Valero; Aman U Buzdar; Marsha D McNeese; Eva Singletary; Gabriel N Hortobagyi
Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.
Clinical breast cancer 2002;3 Suppl 2():S63-8.
2002: Aman U Buzdar
New generation aromatase inhibitors--from the advanced to the adjuvant setting.
Breast cancer research and treatment 2002;75 Suppl 1():S13-7; discussion S33-5.
2002: C Kent Osborne; John Pippen; Stephen E Jones; Leroy M Parker; M Ellis; Steven E Come; Stan Gertler; J T May; G Burton; Isaiah Dimery; Alan Webster; Charles Morris; Richard M Elledge; Aman U Buzdar
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3386-95.
2002: Eugene Huang; Marsha D McNeese; Eric A Strom; George H Perkins; Angela Katz; Gabriel N Hortobagyi; Vicente Valero; Henry M Kuerer; S Eva Singletary; Kelly K Hunt; Aman U Buzdar; Thomas Buchholz
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.
International journal of radiation oncology, biology, physics 2002;53(5):1225-33.
2002: Thomas Buchholz; Angela Katz; Eric A Strom; Marsha D McNeese; George H Perkins; Gabriel N Hortobagyi; Howard D Thames; Henry M Kuerer; S Eva Singletary; Aysegul A Sahin; Kelly K Hunt; Aman U Buzdar; Vicente Valero; Nour Sneige; Susan L Tucker
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
International journal of radiation oncology, biology, physics 2002;53(4):880-8.
2002: Vasily Assikis; Aman U Buzdar
Recent advances in aromatase inhibitor therapy for breast cancer.
Seminars in oncology 2002;29(3 Suppl 11):120-8.
2002: Sharon H Giordano; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi
Efficacy of anastrozole in male breast cancer.
American journal of clinical oncology 2002;25(3):235-7.
2002: Aman U Buzdar; Daniel F Hayes; A El-Khoudary; S Yan; P Lønning; M Lichinitser; R Gopal; G Falkson; Kathleen Pritchard; A Lipton; K Wolter; A Lee; K Fly; R Chew; M Alderdice; K Burke; P Eisenber
Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
Breast cancer research and treatment 2002;73(2):161-75.
2002: Aman U Buzdar; S Eva Singletary; Vicente Valero; Daniel J Booser; Nuhad K Ibrahim; Zia Rahman; Richard L Theriault; Ronald Walters; Edgardo Rivera; Terry L Smith; Frankie A Holmes; Emma Hoy; Debra Frye; Nikki Manuel; Shu-Wan Kau; Marsha D McNeese; Eric A Strom; Eva Thomas; Kelly Hunt; Frederick C Ames; Donald Berry; Gabriel N Hortobagyi
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1073-9.
2002: Lisa A Newman; Aman U Buzdar; S Eva Singletary; Henry M Kuerer; Thomas Buchholz; Frederick C Ames; Merrick I Ross; Kelly K Hunt
A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility.
Annals of surgical oncology 2002;9(3):228-34.
2002: Aman U Buzdar
Superior efficacy of letrozole versus tamoxifen as first-line therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):876-8.
2002: Edgardo Rivera; Frankie A Holmes; Aman U Buzdar; Lina Asmar; Shu-Wan Kau; Giuseppe Fraschini; Ronald Walters; Richard L Theriault; Gabriel N Hortobagyi
Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease.
The breast journal 2002;8(1):2-9.
2002: Thomas Buchholz; Susan L Tucker; Lawrence Masullo; Henry M Kuerer; Jessica Erwin; Jessica Salas; Debra Frye; Eric A Strom; Marsha D McNeese; George Perkins; Angela Katz; S Eva Singletary; Kelly K Hunt; Aman U Buzdar; Gabriel N Hortobagyi
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):17-23.
2001: P E Johnson; Aman U Buzdar
Are differences in the available aromatase inhibitors and inactivators significant?
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12 Suppl):4360s-4368s; discussion 4411s-4412s.
2001: Aman U Buzdar; Steven E Come; Angela Brodie; M Ellis; P E Goss; James N Ingle; Stephen R D Johnston; Adrian V Lee; C Kent Osborne; V G Vogel; Carol S Hart
Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12 Suppl):4335s-4337s; discussion 4411s-4412s.
2001: Aman U Buzdar
A summary of second-line randomized studies of aromatase inhibitors.
The Journal of steroid biochemistry and molecular biology 2001;79(1-5):109-14.
2001: Henry M Kuerer; S Eva Singletary; Aman U Buzdar; Frederick C Ames; V Valero; Thomas Buchholz; Merrick I Ross; L Pusztai; Gabriel N Hortobagyi; Kelly K Hunt
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma.
American journal of surgery 2001;182(6):601-8.
2001: Q Xiong; Vicente Valero; V Kau; Shu-Wan Kau; S Taylor; Terry L Smith; Aman U Buzdar; Gabriel N Hortobagyi; Richard L Theriault
Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience.
Cancer 2001;92(10):2523-8.
2001: Jacques Bonneterre; Aman U Buzdar; Jean-Marc Nabholtz; John F R Robertson; B Thürlimann; Mikael von Euler; T Sahmoud; Alan Webster; M Steinberg
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.
Cancer 2001;92(9):2247-58.
2001: Massimo Cristofanilli; Aman U Buzdar; Nour Sneige; Terry Smith; BJ Wasaff; Nuhad Ibrahim; Daniel J Booser; Edgardo Rivera; James L Murray; Vicente Valero; Naoto T Ueno; Eva Singletary; Kelly Hunt; Eric A Strom; Marsha D McNeese; Carol B Stelling; Gabriel N Hortobagyi
Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.
Cancer 2001;92(7):1775-82.
2001: Aman U Buzdar; A Howell
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2620-35.
2001: Aman U Buzdar; J Douma; Nancy E Davidson; Richard M Elledge; M Morgan; R Smith; L Porter; Jean-Marc Nabholtz; X Xiang; C Brady
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3357-66.
2001: Georges Vlastos; ME Jean; Attiqa N Mirza; Nadeem Q Mirza; Henry M Kuerer; Frederick C Ames; Kelly K Hunt; Merrick I Ross; Thomas Buchholz; Aman U Buzdar; S Eva Singletary
Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases.
Annals of surgical oncology 2001;8(5):425-31.
2001: Aman U Buzdar
Endocrine therapy in the treatment of metastatic breast cancer.
Seminars in oncology 2001;28(3):291-304.
2001: Henry M Kuerer; Aman U Buzdar; S Eva Singletary
Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast.
Journal of surgical oncology 2001;77(2):139-47.
2001: Thomas Buchholz; Susan L Tucker; J Erwin; D Mathur; Eric A Strom; Marsha D McNeese; Gabriel N Hortobagyi; Massimo Cristofanilli; Francisco J Esteva; Lisa A Newman; S Eva Singletary; Aman U Buzdar; Kelly K Hunt
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2240-6.
2001: Lisa A Newman; Henry M Kuerer; Bruno D Fornage; Nadeem Mirza; Kelly K Hunt; Merrick I Ross; Frederick C Ames; Aman U Buzdar; S Eva Singletary
Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer.
American journal of surgery 2001;181(4):313-8.
2001: Pamela N Münster; Aman U Buzdar; Kapil Dhingra; N Enas; L Ni; M Major; Allen S Melemed; Andrew D Seidman; Daniel J Booser; Richard Theriault; Larry Norton; Clifford Hudis
Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):2002-9.
2001: Nuhad K Ibrahim; Aman U Buzdar; Vicente Valero; Kapil Dhingra; Jie Willey; Gabriel N Hortobagyi
Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.
Cancer 2001;91(4):664-71.
2001: R A Brito; Vicente Valero; Aman U Buzdar; Daniel J Booser; Frederick C Ames; Eric A Strom; M Ross; Richard L Theriault; Debra Frye; Shu-Wan Kau; Lina Asmar; Marsha D McNeese; S Eva Singletary; Gabriel N Hortobagyi
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):628-33.
2001: Laura B Michaud; K L Jones; Aman U Buzdar
Combination endocrine therapy in the management of breast cancer.
The oncologist 2001;6(6):538-46.
2001: Nuhad K Ibrahim; Vicente Valero; Zia Rahman; Richard L Theriault; Ronald S Walters; Aman U Buzdar; Daniel J Booser; Frankie A Holmes; James L Murray; Jie Willey; Robert C Bast; Gabriel N Hortobagyi
Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.
Cancer investigation 2001;19(5):459-66.
2001: Francisco J Esteva; V Valero; Lajos Pusztai; L Boehnke-Michaud; Aman U Buzdar; G N Hortobagyi
Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond.
The oncologist 2001;6(2):133-46.
2000: Nuhad K Ibrahim; Aman U Buzdar; Lina Asmar; Richard L Theriault; Gabriel N Hortobagyi
Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1597-601.
2000: Edgardo Rivera; Frankie A Holmes; Debra Frye; Vicente Valero; Richard L Theriault; Daniel J Booser; Ronald Walters; Aman U Buzdar; Kapil Dhingra; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.
Cancer 2000;89(11):2195-201.
2000: Jean-Marc Nabholtz; Aman U Buzdar; M Pollak; W Harwin; G Burton; A Mangalik; M Steinberg; Alan Webster; Mikael von Euler
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3758-67.
2000: Shine Chang; J R Alderfer; Lina Asmar; Aman U Buzdar
Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis.
Breast cancer research and treatment 2000;64(2):157-63.
2000: Tara M Breslin; Lorenzo Cohen; Aysegul Sahin; Jason Fleming; Henry M Kuerer; Lisa A Newman; Ebrahim S Delpassand; R House; Frederick C Ames; Barry W Feig; Merrick I Ross; S Eva Singletary; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3480-6.
2000: Aman U Buzdar
Exemestane in advanced breast cancer.
Anti-cancer drugs 2000;11(8):609-16.
2000: Aman U Buzdar
Tamoxifen's clinical applications: old and new.
Archives of family medicine 2000;9(9):906-12.
2000: Georges Vlastos; I T Rubio; Nadeem Q Mirza; Lisa A Newman; R Aurora; J Alderfer; Aman U Buzdar; S Eva Singletary
Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer.
Annals of surgical oncology 2000;7(8):581-7.
2000: Angela Katz; Eric A Strom; Thomas Buchholz; Howard D Thames; C D Smith; Anuja Jhingran; Gabriel N Hortobagyi; Aman U Buzdar; Richard Theriault; S Eva Singletary; Marsha D McNeese
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(15):2817-27.
2000: Zhongxing Liao; Eric A Strom; Aman U Buzdar; S Eva Singletary; K Hunt; Pamela K Allen; Marsha D McNeese
Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
International journal of radiation oncology, biology, physics 2000;47(5):1191-200.
2000: Funda Meric; Nadeem Q Mirza; Aman U Buzdar; Kelly K Hunt; Frederick C Ames; Merrick I Ross; Raphael E Pollock; Lisa A Newman; Barry W Feig; Eric A Strom; Thomas Buchholz; Marsha D McNeese; Gabriel N Hortobagyi; S Eva Singletary
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.
Annals of surgical oncology 2000;7(6):435-40.
2000: Georges Vlastos; Bruno D Fornage; Nadeem Q Mirza; Deepak G Bedi; Jeffrey T Lenert; D J Winchester; Susanne Tolley; Frederick C Ames; Merrick I Ross; Barry W Feig; Kelly K Hunt; Aman U Buzdar; S Eva Singletary
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy.
American journal of surgery 2000;179(6):446-52.
2000: Paulo M Hoff; Vicente Valero; Aman U Buzdar; S Eva Singletary; Richard L Theriault; Daniel J Booser; Lina Asmar; Debra Frye; Marsha D McNeese; Gabriel N Hortobagyi
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
Cancer 2000;88(9):2054-60.
2000: Laura B Michaud; Aman U Buzdar
Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.
Drugs & aging 2000;16(4):261-71.
2000: Nuhad K Ibrahim; Vicente Valero; Richard L Theriault; Jie Willey; Ronald S Walters; Aman U Buzdar; Daniel J Booser; Gabriel N Hortobagyi
Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.
American journal of clinical oncology 2000;23(2):117-21.
2000: Georges Vlastos; Nadeem Q Mirza; Jeffrey T Lenert; Kelly K Hunt; Frederick C Ames; Barry W Feig; Merrick I Ross; Aman U Buzdar; S Eva Singletary
The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy.
Cancer 2000;88(6):1417-24.
2000: Gabriel N Hortobagyi; Aman U Buzdar; Richard L Theriault; Vicente Valero; Debra Frye; Daniel J Booser; Frankie A Holmes; Sergio Giralt; Issa Khouri; Borje Andersson; James L Gajewski; Gabriela Rondon; T L Smith; S E Singletary; F C Ames; N Sneige; Eric A Strom; Marsha D McNeese; Albert Deisseroth; Richard E Champlin
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Journal of the National Cancer Institute 2000;92(3):225-33.
2000: Anne C Kushwaha; Gary J Whitman; Carol B Stelling; Massimo Cristofanilli; Aman U Buzdar
Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings.
AJR. American journal of roentgenology 2000;174(2):535-8.
2000: Nuhad K Ibrahim; A A Sahin; R A Dubrow; P M Lynch; L Boehnke-Michaud; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi
Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.
Lancet 2000;355(9200):281-3.
1999: Jeffrey T Lenert; Georges Vlastos; Nadeem Q Mirza; D J Winchester; SM Binkley; Frederick C Ames; Merrick I Ross; Barry W Feig; Kelly K Hunt; Eric A Strom; Aman U Buzdar; Gabriel N Hortobagyi; S Eva Singletary
Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients.
Annals of surgical oncology 1999;6(8):762-7.
1999: John F R Robertson; A Howell; Aman U Buzdar; Mikael von Euler; D Lee
Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer.
Breast cancer research and treatment 1999;58(2):157-62.
1999: Aman U Buzdar; S Eva Singletary; Richard L Theriault; Daniel J Booser; Vicente Valero; Nuhad Ibrahim; Terry L Smith; Lina Asmar; Debra Frye; N Manuel; Shu-Wan Kau; Marsha D McNeese; Eric A Strom; Kelly Hunt; Frederick C Ames; Gabriel N Hortobagyi
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3412-7.
1999: Laura B Michaud; Aman U Buzdar
Risks and benefits of aromatase inhibitors in postmenopausal breast cancer.
Drug safety : an international journal of medical toxicology and drug experience 1999;21(4):297-309.
1999: Nuhad K Ibrahim; Zia Rahman; Vicente Valero; Jie Willey; Richard L Theriault; Aman U Buzdar; James L Murray; Robert C Bast; Gabriel N Hortobagyi
Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.
Cancer 1999;86(7):1251-7.
1999: Aman U Buzdar; Gabriel N Hortobagyi
Recent advances in adjuvant therapy of breast cancer.
Seminars in oncology 1999;26(4 Suppl 12):21-7.
1999: Gabriel N Hortobagyi; Mien-Chie Hung; Aman U Buzdar
Recent developments in breast cancer therapy.
Seminars in oncology 1999;26(4 Suppl 12):11-20.
1999: Henry M Kuerer; Aysegul A Sahin; Kelly K Hunt; Lisa A Newman; Tara M Breslin; Frederick C Ames; Merrick I Ross; Aman U Buzdar; Gabriel N Hortobagyi; S Eva Singletary
Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Annals of surgery 1999;230(1):72-8.
1999: Aman U Buzdar
Role of aromatase inhibitors in advanced breast cancer.
Endocrine-related cancer 1999;6(2):219-25.
1999: Thomas Buchholz; Kelly K Hunt; C M Amosson; S L Tucker; Eric A Strom; Marsha D McNeese; Aman U Buzdar; S Eva Singletary; Gabriel N Hortobagyi
Sequencing of chemotherapy and radiation in lymph node-negative breast cancer.
The cancer journal from Scientific American 1999;5(3):159-64.
1999: Vicente Valero; Aman U Buzdar; Richard L Theriault; Nozar Azarnia; G A Fonseca; Jie Willey; Michael S Ewer; Ronald S Walters; B Mackay; Donald A Podoloff; Daniel J Booser; L W Lee; Gabriel N Hortobagyi
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1425-34.
1999: M Cristofanilli; Frankie A Holmes; L Esparza; V Valero; Aman U Buzdar; J A Neidhart; Gabriel N Hortobagyi
Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience.
Breast cancer research and treatment 1999;54(3):225-33.
1999: Frankie A Holmes; Vicente Valero; Ronald S Walters; Richard L Theriault; Daniel J Booser; H Gibbs; Giuseppe Fraschini; Aman U Buzdar; Jie Willey; Debra Frye; Lina Asmar; Gabriel N Hortobagyi
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):403-11.
1999: D L Berry; Richard L Theriault; Frankie A Holmes; Valerie Parisi; Daniel J Booser; S Eva Singletary; Aman U Buzdar; Gabriel N Hortobagyi
Management of breast cancer during pregnancy using a standardized protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):855-61.
1999: Henry M Kuerer; Lisa A Newman; Terry L Smith; Frederick C Ames; Kelly K Hunt; Kapil Dhingra; Richard L Theriault; G Singh; SM Binkley; Nour Sneige; Thomas Buchholz; Merrick I Ross; Marsha D McNeese; Aman U Buzdar; Gabriel N Hortobagyi; S Eva Singletary
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):460-9.
1999: Nuhad K Ibrahim; Gabriel N Hortobagyi; Michael S Ewer; M K Ali; Lina Asmar; Richard L Theriault; Giuseppe Fraschini; Debra Frye; Aman U Buzdar
Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience.
Cancer chemotherapy and pharmacology 1999;43(6):471-8.
1999: Zia Rahman; Debra Frye; Terry L Smith; Lina Asmar; Richard L Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference.
Cancer 1999;85(1):104-11.
1998: Henry M Kuerer; Lisa A Newman; Aman U Buzdar; Kelly K Hunt; Kapil Dhingra; Thomas Buchholz; SM Binkley; Frederick C Ames; Barry W Feig; Merrick I Ross; Gabriel N Hortobagyi; S Eva Singletary
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
American journal of surgery 1998;176(6):502-9.
1998: Henry M Kuerer; Lisa A Newman; Bruno D Fornage; Kapil Dhingra; Kelly K Hunt; Aman U Buzdar; Frederick C Ames; Merrick I Ross; Barry W Feig; Gabriel N Hortobagyi; S Eva Singletary
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.
Annals of surgical oncology 1998;5(8):673-80.
1998: Susan Chang; Aman U Buzdar; S D Hursting
Inflammatory breast cancer and body mass index.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3731-5.
1998: Aman U Buzdar; W Jonat; A Howell; Stephen E Jones; C P Blomqvist; Charles L Vogel; W Eiermann; JM Wolter; M Steinberg; A Webster; D Lee
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
Cancer 1998;83(6):1142-52.
1998: Aman U Buzdar
The place of chemotherapy in the treatment of early breast cancer.
British journal of cancer 1998;78 Suppl 4():16-20.
1998: Z U Rahman; Gabriel N Hortobagyi; Aman U Buzdar; R Champlin
High-dose chemotherapy with autologous stem cell support in patients with breast cancer.
Cancer treatment reviews 1998;24(4):249-63.
1998: Henry M Kuerer; Lisa A Newman; Aman U Buzdar; Kapil Dhingra; Kelly K Hunt; Thomas Buchholz; SM Binkley; Eric A Strom; Frederick C Ames; Merrick I Ross; Barry W Feig; Marsha D McNeese; Gabriel N Hortobagyi; S Eva Singletary
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
The cancer journal from Scientific American 1998;4(4):230-6.
1998: S Chang; S L Parker; T Pham; Aman U Buzdar; S D Hursting
Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
Cancer 1998;82(12):2366-72.
1998: EA Diaz-Canton; Vicente Valero; Zia Rahman; EJ Rodriguez-Monge; Debra Frye; T Smith; Aman U Buzdar; Gabriel N Hortobagyi
Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):413-8.
1998: Aman U Buzdar
Anastrozole: a new addition to the armamentarium against advanced breast cancer.
American journal of clinical oncology 1998;21(2):161-6.
1998: Aman U Buzdar; Gabriel N Hortobagyi
Update on endocrine therapy for breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):527-34.
1998: Gabriel N Hortobagyi; Aman U Buzdar
Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.
Cancer investigation 1998;16(6):385-90.
1998: Aman U Buzdar; G N Hortobagyi
Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):348-53.
1997: A Y Kinney; Aysegul Sahin; Sally W Vernon; Ralph F Frankowski; John F Annegers; Gabriel N Hortobagyi; Aman U Buzdar; Debra Frye; Kapil Dhingra
The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy.
Cancer 1997;80(12):2240-9.
1997: BJ Roseman; Aman U Buzdar; S Eva Singletary
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Journal of surgical oncology 1997;66(3):215-20.
1997: Gabriel N Hortobagyi; Jie Willey; Zia Rahman; Frankie A Holmes; Richard L Theriault; Aman U Buzdar
Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-65-S17-68.
1997: Aman U Buzdar; Gabriel N Hortobagyi; Lina Asmar; Richard L Theriault; Zia Rahman; Marsha D McNeese; S Eva Singletary; Frederick C Ames
Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-31-S17-34.
1997: Zia Rahman; Debra Frye; Aman U Buzdar; Terry L Smith; Lina Asmar; Richard E Champlin; Gabriel N Hortobagyi
Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3171-7.
1997: J Herrada; Revathy B Iyer; E Neely Atkinson; Nour Sneige; Aman U Buzdar; Gabriel N Hortobagyi
Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1565-9.
1997: T Inoue; E Edmund Kim; Sidney Wallace; David J Yang; Franklin C Wong; P Bassa; Aman U Buzdar; Donald A Podoloff
Preliminary study of cardiac accumulation of F-18 fluorotamoxifen in patients with breast cancer.
Clinical imaging 1997;21(5):332-6.
1997: RY Fleming; L Asmar; Aman U Buzdar; Marsha D McNeese; Frederick C Ames; Merrick I Ross; S Eva Singletary
Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma.
Annals of surgical oncology 1997;4(6):452-61.
1997: Gabriel N Hortobagyi; Frankie A Holmes; Richard L Theriault; Zia Rahman; Aman U Buzdar
Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer.
Seminars in oncology 1997;24(4 Suppl 11):S11-13-S11-19.
1997: Aman U Buzdar; Walter Jonat; A Howell; P V Plourde
ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer.
The Journal of steroid biochemistry and molecular biology 1997;61(3-6):145-9.
1997: Aman U Buzdar; Stephen E Jones; Charles L Vogel; JM Wolter; P Plourde; A Webster
A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
Cancer 1997;79(4):730-9.
1997: Gabriel N Hortobagyi; Frankie A Holmes; N Ibrahim; Richard Champlin; Aman U Buzdar
The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
Seminars in oncology 1997;24(1 Suppl 3):S30-3.
1997: Naoto T Ueno; Aman U Buzdar; S E Singletary; F C Ames; Marsha D McNeese; Frankie A Holmes; Richard L Theriault; Eric A Strom; BJ Wasaff; Lina Asmar; Debra Frye; Gabriel N Hortobagyi
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
Cancer chemotherapy and pharmacology 1997;40(4):321-9.
1996: E Diamandidou; Aman U Buzdar; Terry L Smith; Debra Frye; M Witjaksono; Gabriel N Hortobagyi
Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2722-30.
1996: Frankie A Holmes; Timothy Madden; Robert A Newman; Vicente Valero; Richard L Theriault; Giuseppe Fraschini; Ronald S Walters; Daniel J Booser; Aman U Buzdar; Jie Willey; Gabriel N Hortobagyi
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2713-21.
1996: T Inoue; E Edmund Kim; Sidney Wallace; David J Yang; Franklin C Wong; P Bassa; A Cherif; Ebrahim S Delpassand; Aman U Buzdar; Donald A Podoloff
Positron emission tomography using [18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study.
Cancer biotherapy & radiopharmaceuticals 1996;11(4):235-45.
1996: Aman U Buzdar; P V Plourde; Gabriel N Hortobagyi
Aromatase inhibitors in metastatic breast cancer.
Seminars in oncology 1996;23(4 Suppl 9):28-32.
1996: P A Greenberg; Gabriel N Hortobagyi; Terry L Smith; L D Ziegler; Debra Frye; Aman U Buzdar
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(8):2197-205.
1996: Aman U Buzdar; W Jonat; A Howell; Stephen E Jones; C Blomqvist; Charles L Vogel; W Eiermann; JM Wolter; M Azab; A Webster; P V Plourde
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2000-11.
1996: Aman U Buzdar; R Smith; Charles L Vogel; P Bonomi; A M Keller; G Favis; M Mulagha; J Cooper
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
Cancer 1996;77(12):2503-13.
1996: P Bassa; E Edmund Kim; T Inoue; Franklin C Wong; M Korkmaz; David J Yang; W H Wong; K W Hicks; Aman U Buzdar; Donald A Podoloff
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):931-8.
1996: J Y Payne; Frankie A Holmes; Philip R Cohen; Robert Gagel; Aman U Buzdar; Kapil Dhingra
Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
Southern medical journal 1996;89(5):542-5.
1996: Nuhad K Ibrahim; Debra Frye; Aman U Buzdar; Ronald S Walters; Gabriel N Hortobagyi
Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome.
Archives of internal medicine 1996;156(8):882-8.
1996: E M Mora; S Eva Singletary; Aman U Buzdar; D A Johnston
Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients.
Annals of surgical oncology 1996;3(2):162-8.
1995: Vicente Valero; Frankie A Holmes; Ronald S Walters; Richard L Theriault; L Esparza; Giuseppe Fraschini; G A Fonseca; R E Bellet; Aman U Buzdar; Gabriel N Hortobagyi
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2886-94.
1995: Aman U Buzdar; S Eva Singletary; Daniel J Booser; Debra Frye; B Wasaff; Gabriel N Hortobagyi
Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience.
Surgical oncology clinics of North America 1995;4(4):715-34.
1995: Nuhad K Ibrahim; Aman U Buzdar
Aromatase inhibitors: current status.
American journal of clinical oncology 1995;18(5):407-17.
1995: Kapil Dhingra; H Fritsche; James L Murray; A F LoBuglio; M B Khazaeli; S Kelley; Mark Tepper; D Grasela; Aman U Buzdar; Vicente Valero
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.
Cancer research 1995;55(14):3060-7.
1995: Aman U Buzdar; Frankie A Holmes; Gabriel N Hortobagyi
Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience.
Seminars in oncology 1995;22(3 Suppl 6):101-4.
1995: I A Jaiyesimi; Aman U Buzdar; D A Decker; Gabriel N Hortobagyi
Use of tamoxifen for breast cancer: twenty-eight years later.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):513-29.
1994: Aman U Buzdar; L Esparza; R Natale; R Cody; Kathleen A Calzone; A B Benson; T Sheehan; W Berry
Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study.
American journal of clinical oncology 1994;17(5):417-21.
1994: Gabriel N Hortobagyi; Frankie A Holmes; R L Theriault; Aman U Buzdar
Use of Taxol (paclitaxel) in breast cancer.
Oncology 1994;51 Suppl 1():29-32.
1994: Aman U Buzdar; S Kau; Gabriel N Hortobagyi; Richard L Theriault; Daniel J Booser; Frankie A Holmes; R Walters; I H Krakoff
Phase I trial of droloxifene in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 1994;33(4):313-6.
1994: Aman U Buzdar; Gabriel N Hortobagyi; Debra Frye; D Ho; Daniel J Booser; Vicente Valero; Frankie A Holmes; B K Birmingham; K Bui; C Yeh
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):50-4.
1994: J Bastarrachea; G N Hortobagyi; Terry L Smith; S W Kau; Aman U Buzdar
Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.
Annals of internal medicine 1994;120(1):18-25.
1994: David J Yang; Chun Li; L R Kuang; J E Price; Aman U Buzdar; W Tansey; A Cherif; M Gretzer; E Edmund Kim; Sidney Wallace
Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues.
Life sciences 1994;55(1):53-67.
1994: Kapil Dhingra; H Fritsche; James L Murray; A F LoBuglio; M B Khazaeli; S Kelley; Mark Tepper; D Greene; Daniel J Booser; Aman U Buzdar
Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study.
Advances in experimental medicine and biology 1994;353():193-202.
1994: Kapil Dhingra; Vicente Valero; L Gutierrez; Richard L Theriault; Daniel J Booser; Frankie A Holmes; Aman U Buzdar; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of deoxyspergualin in metastatic breast cancer.
Investigational new drugs 1994;12(3):235-41.
1993: Aman U Buzdar; S W Kau; Terry L Smith; Frederick C Ames; Eva Singletary; Eric A Strom; Marsha D McNeese; Gabriel N Hortobagyi
The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer.
Cancer 1993;71(11):3680-4.
1992: Richard L Theriault; C B Stallings; Aman U Buzdar
Pregnancy and breast cancer: clinical and legal issues.
American journal of clinical oncology 1992;15(6):535-9.
1992: I A Jaiyesimi; Aman U Buzdar; A A Sahin; M A Ross
Carcinoma of the male breast.
Annals of internal medicine 1992;117(9):771-7.
1992: Aman U Buzdar; Gabriel N Hortobagyi; S W Kau; Terry L Smith; Giuseppe Fraschini; Frankie A Holmes; Jordan U Gutterman; V M Hug; S Eva Singletary; Frederick C Ames
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1540-6.
1992: I A Jaiyesimi; Aman U Buzdar; Gabriel N Hortobagyi
Inflammatory breast cancer: a review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):1014-24.
1992: I A Jaiyesimi; Aman U Buzdar
Adjuvant chemotherapy in high-risk breast cancer patients with ten or more positive lymph nodes.
American journal of clinical oncology 1992;15(2):180-3.
1992: Ronald S Walters; Debra Frye; Aman U Buzdar; Frankie A Holmes; Gabriel N Hortobagyi
A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma.
Cancer 1992;69(2):476-81.
1992: Aman U Buzdar; S W Kau; Gabriel N Hortobagyi; Frederick C Ames; Frankie A Holmes; Giuseppe Fraschini; V Hug; Richard L Theriault; Marsha D McNeese; S Eva Singletary
Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.
Cancer 1992;69(2):448-52.
1992: J R Simmons; Aman U Buzdar; D M Ota; K Marts; Gabriel N Hortobagyi
Complications associated with indwelling catheters.
Medical and pediatric oncology 1992;20(1):22-5.
1991: Frankie A Holmes; Ronald S Walters; Richard L Theriault; A D Forman; L K Newton; Martin N Raber; Aman U Buzdar; Debra Frye; Gabriel N Hortobagyi
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
Journal of the National Cancer Institute 1991;83(24):1797-805.
1991: Giuseppe Fraschini; Frankie A Holmes; L Esparza; Richard L Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Phase I-II study of high-dose etoposide in patients with refractory breast cancer.
Investigational new drugs 1991;9(4):365-7.
1991: J E Macheledt; Aman U Buzdar; Gabriel N Hortobagyi; Debra Frye; J U Gutterman; Frankie A Holmes
Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.
Breast cancer research and treatment 1991;18(3):165-70.
1991: L M Lamki; Aman U Buzdar; S E Singletary; Michael G Rosenblum; V Bhadkamkar; L Esparza; Donald A Podoloff; A Zukiwski; G N Hortobagyi; James L Murray
Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(7):1326-32.
1991: L D Ziegler; Aman U Buzdar
Recent advances in the treatment of breast cancer.
The American journal of the medical sciences 1991;301(5):337-52.
1991: L D Ziegler; Aman U Buzdar
Current status of adjuvant therapy of early breast cancer.
American journal of clinical oncology 1991;14(2):101-10.
1990: R Wallerstein; G Spitzer; Frank Dunphy; SD Huan; Gabriel N Hortobagyi; JC Yau; Aman U Buzdar; Frankie A Holmes; Richard L Theriault; Michael S Ewer
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1782-8.
1990: Frank Dunphy; G Spitzer; Aman U Buzdar; Gabriel N Hortobagyi; L J Horwitz; JC Yau; J A Spinolo; Sundar Jagannath; Frankie A Holmes; R O Wallerstein
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1207-16.
1990: Frankie A Holmes; Herbert A Fritsche; J W Loewy; A M Geitner; R C Sutton; Aman U Buzdar; Gabriel N Hortobagyi
Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):1025-35.
1990: R Sutton; Aman U Buzdar; Gabriel N Hortobagyi
Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients.
Cancer 1990;65(4):847-50.
1990: Aman U Buzdar; Marsha D McNeese; Gabriel N Hortobagyi; Terry L Smith; S Kau; Giuseppe Fraschini; V Hug; N Ellerbroek; Frankie A Holmes; Frederick C Ames
Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?
Cancer 1990;65(3):394-9.
1990: Aman U Buzdar; Gabriel N Hortobagyi; L T Esparza; Frankie A Holmes; J S Ro; Giuseppe Fraschini; B Lichtiger
Elliptinium acetate in metastatic breast cancer--a phase II study.
Oncology 1990;47(2):101-4.
1990: Gabriel N Hortobagyi; Richard L Theriault; Debra Frye; Ronald S Walters; Giuseppe Fraschini; C K Tashima; J S Ro; E Salewski; Aman U Buzdar
Pirarubicin in combination chemotherapy for metastatic breast cancer.
American journal of clinical oncology 1990;13 Suppl 1():S54-6.
1990: E H Koh; Aman U Buzdar; Frederick C Ames; S Eva Singletary; Marsha D McNeese; Debra Frye; Frankie A Holmes; Giuseppe Fraschini; V Hug; Richard L Theriault
Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
Cancer chemotherapy and pharmacology 1990;27(2):94-100.
1990: Aman U Buzdar
Current status of endocrine treatment of carcinoma of the breast.
Seminars in surgical oncology 1990;6(2):77-82.
1990: N Vanek; Gabriel N Hortobagyi; Aman U Buzdar
Radiotherapy enhances the toxicity of aminoglutethimide.
Medical and pediatric oncology 1990;18(2):162-4.
1990: Richard L Theriault; Aman U Buzdar
Acute superior vena caval thrombosis after central venous catheter removal: successful treatment with thrombolytic therapy.
Medical and pediatric oncology 1990;18(1):77-80.
1989: P T Ang; Aman U Buzdar; Terry L Smith; S Kau; Gabriel N Hortobagyi
Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1677-84.
1989: H Z Patel; Aman U Buzdar; Gabriel N Hortobagyi
Role of adjuvant chemotherapy in male breast cancer.
Cancer 1989;64(8):1583-5.
1989: Gabriel N Hortobagyi; V Hug; Aman U Buzdar; S W Kau; Frankie A Holmes; H A Fritsche
Sequential cyclic combined hormonal therapy for metastatic breast cancer.
Cancer 1989;64(5):1002-6.
1989: Aman U Buzdar; S W Kau; Terry L Smith; Gabriel N Hortobagyi
Ten-year results of FAC adjuvant chemotherapy trial in breast cancer.
American journal of clinical oncology 1989;12(2):123-8.
1989: Richard L Theriault; Gabriel N Hortobagyi; H A Fritsche; Debra Frye; R Martinez; Aman U Buzdar
The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.
Cancer 1989;63(5):828-35.
1989: P S Chu; Aman U Buzdar; Gabriel N Hortobagyi
Trilostane with hydrocortisone in treatment of metastatic breast cancer.
Breast cancer research and treatment 1989;13(2):117-21.
1989: Gabriel N Hortobagyi; Debra Frye; Aman U Buzdar; Michael S Ewer; Giuseppe Fraschini; V Hug; Frederick C Ames; E Montague; C H Carrasco; Bruce Mackay
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.
Cancer 1989;63(1):37-45.
1988: Gabriel N Hortobagyi; Frederick C Ames; Aman U Buzdar; S W Kau; Marsha D McNeese; D Paulus; V Hug; Frankie A Holmes; MM Romsdahl; Giuseppe Fraschini
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
Cancer 1988;62(12):2507-16.
1988: Richard L Theriault; Gabriel N Hortobagyi; S W Kau; Frankie A Holmes; V Hug; Giuseppe Fraschini; K Jabboury; Aman U Buzdar
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Cancer 1988;62(10):2105-10.
1988: Aman U Buzdar; Gabriel N Hortobagyi; Terry L Smith; S Kau; C Marcus; Frankie A Holmes; V Hug; Giuseppe Fraschini; Frederick C Ames; R G Martin
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Cancer 1988;62(10):2098-104.
1988: Gabriel N Hortobagyi; Aman U Buzdar
Management of locally advanced breast cancer.
American journal of clinical oncology 1988;11(5):597-601.
1988: Giuseppe Fraschini; Frankie A Holmes; Aman U Buzdar; V Hug; Gabriel N Hortobagyi
Cisplatin in combination with continuous infusion vinblastine for refractory breast cancer.
American journal of clinical oncology 1988;11(4):448-50.
1988: Aman U Buzdar
Chemotherapeutic approaches to advanced breast cancer.
Seminars in oncology 1988;15(3 Suppl 4):65-70.
1988: E Berté; Aman U Buzdar; Terry L Smith; Gabriel N Hortobagyi
Bilateral primary breast cancer in patients treated with adjuvant therapy.
American journal of clinical oncology 1988;11(2):114-8.
1988: Giuseppe Fraschini; Chusilp Charnsangavej; C H Carrasco; Aman U Buzdar; K W Jabboury; Gabriel N Hortobagyi
Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver.
American journal of clinical oncology 1988;11(1):34-8.
1988: Aman U Buzdar; C Marcus; Frankie A Holmes; V Hug; Gabriel N Hortobagyi
Phase II evaluation of Ly156758 in metastatic breast cancer.
Oncology 1988;45(5):344-5.
1987: Gabriel N Hortobagyi; Aman U Buzdar; Debra Frye; V Hug; Giuseppe Fraschini; Frederick C Ames; E Montague; Jordan U Gutterman; R G Martin
Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial.
Cancer 1987;60(11):2596-604.
1987: Frankie A Holmes; H Y Yap; L Esparza; Aman U Buzdar; G R Blumenschein; V Hug; G N Hortobagyi
Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy.
Cancer 1987;59(12):1992-9.
1986: Frankie A Holmes; L Esparza; H Y Yap; Aman U Buzdar; G R Blumenschein; G N Hortobagyi
A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 1986;18(2):157-61.
1984: Frankie A Holmes; H Y Yap; L Esparza; Aman U Buzdar; G N Hortobagyi; G R Blumenschein
Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer.
Seminars in oncology 1984;11(3 Suppl 1):28-31.